Objectives To develop a universally applicable test instrument to measure the total direct costs of urinary incontinence, including personal costs and treatment costs, i.e. the Dowell-Bryant Incontinence Cost Index (DBICI). and to study the construct validity and test-retest reliability of the instrument.
Patients and methods In a prospective observational study, 100 consecutive community-dwelling ambulatory women who presented with stress, urge or mixed incontinence were asked to complete the DBICI questionnaire on two occasions, 7 days apart, before any treatment.
The construct validity of the DBICI was ascertained by correlation with other standard measures of urinary incontinence severity ; (i) a visual analogue scale (VAS) to assess the impact of leakage upon lifestyle :
The construct validity of the DBICI was ascertained by correlation with other standard measures of urinary incontinence severity ;
(ii) frequency-volume charts (voids/24 h, leaks/week) ;
(iii) urine loss during a standard 1 h pad test : and (iv) two disease-specific quality of life questionnaires.
The test-retest reliability was measured by comparing the two test results and the construct validity of the individual subsets (personal and treatment) of the DBICI similarly assessed.
Results Ninety-seven women completed the baseline assessment and 84 completed the re-test.
The median (interquartile range) total direct incontinence cost (in Au$) was 12.89 (5.26-22.67) per week, which comprised the median personal costs of 5.61 (1.68-10.36) and the median treatment costs of 4.96 (1.22-13.37). (...)
Mots-clés Pascal : Incontinence urinaire, Coût, Technique mesure, Traitement, Personnel sanitaire, Fiabilité, Validité, Echelle évaluation, Australie, Océanie, Femelle, Homme, Epidémiologie, Appareil urinaire pathologie, Voie urinaire pathologie, Vessie pathologie, Trouble miction
Mots-clés Pascal anglais : Urinary incontinence, Costs, Measurement technique, Treatment, Health staff, Reliability, Validity, Evaluation scale, Australia, Oceania, Female, Human, Epidemiology, Urinary system disease, Urinary tract disease, Bladder disease, Voiding dysfunction
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0239634
Code Inist : 002B14E02. Création : 16/11/1999.